Pharmacoeconomic assessment of providing patients with tableted non-narcotic opioid analgestics upon their discharge from the hospital: opportunities and realities

DOI: https://doi.org/10.29296/25419218-2022-08-08
Issue: 
8
Year: 
2022

A.L. Mymrina(1, 4), L.N. Geller(2), I.G. Mugatasimov(3), I.V. Golubeva(4)
1-NSIFTPh – Branch Campus of the FSBEI FPE RMACPE MOH Russia, 5, Stroiteley street Novokuznetsk city, Kemerovo region - Kuzbass, 654005, Russian Federation; 2-Irkutsk State Medical University, Krasny Vosstaniya str., 2, Irkutsk, 664003, Russian Federation; 3-G.P. Kurbatov Novokuznetsk City Hospital One, Bardina Ave., 30, Novokuznetsk, 654000, Russian Federation; 4-JSC «Organika», Novokuznetsk, Kuznetsk Highway, 3,

The balance of the drug portfolio of healthcare facilities contributes to the prolongation of the provision of medical care at the proper level, ensuring interaction and continuity between the inpatient and outpatient stages of care, which is especially important in organizing and conducting pain syndrome therapy. Currently, the patient's need for pain therapy already at the time of discharge from the hospital before an appointment with an outpatient doctor is expressed by the legislative possibility of handing over potent drugs to the patient for a period of up to 5 days. Objectives: justification of medicine provision with a fixed-dose combination (FDC) of Paracetamol and Tramadol to patients with pain syndrome during their transition from inpatient to outpatient care based on a pharmacoeconomic approach and to evaluate the costs of such pharmacotherapy. Material and methods. The results of previous studies on the evaluation of the effectiveness of the analgesic action of the Paracetamol and Tramadol FDC in comparison with the injectable monodrug Tramadol product and the cost of obtaining 1 unit of effectiveness in the conditions of emergency surgical and trauma departments of a hospital, content analysis of legislation and internal regulations on the circulation of drugs of controlled groups, statistics of the bed capacity of the emergency surgery department for the period of 2021–2022. Results and discussion. The use of Paracetamol and Tramadol FDC for pain therapy, taking into account the comparison and grouping of patients, made it possible to reduce the cost of pain syndrome therapy by 23,472.68 rubles within 4 months. Extrapolation of the obtained data for 4 months for an annual period showed the possibility of reducing the cost of treating pain syndrome by 70,418.04 rubles while ensuring a comfortable transition of patients to outpatient care. Conclusion. The studies show the clinical and economic feasibility of using a Paracetamol and Tramadol FDC both in hospital care and when moving from a hospital to an outpatient clinic.

Keywords: 
pain syndrome
fixed combination of Tramadol+Paracetamol
costs.

References: 
  1. Палехов А.В., Введенская Е.С. Вопросы выбора опиоидных анальгетиков в практике врача-терапевта. Боткинские чтения: материалы всероссийского терапевтического конгресса с международным участием; под ред. академика РАН Мазурова В.И., доцента Трофимова Е.А. СПб.: Изд-во «Человек и его здоровье», 2019; 191–2. [Palekhov A.V., Vvedenskaya E.S. The choice of opioid analgesics in the practice of a general practitioner. Botkin readings: materials of the All–Russian Therapeutic Congress with international participation; edited by academician of the Russian Academy of Sciences V.I. Mazurov, Associate Professor E.A. Trofimov. St. Petersburg: Publishing House «Man and his Health», 2019; 191–2 (in Russian)].
  2. Мымрина А.Л., Кан С.Л., Мугатасимов И.Г., Шапкина В.А., Аксенов Е.Ю., Поветьев А.В., Голубева И.В. Эффективность фиксированной комбинации парацетамола и трамадола в пероральной лекарственной форме в условиях хирургической и травматологической практиким. Врач. 2021; 32 (11): 70–3. [Mymrina A.L., Kan S.L., Mugatasimov I.G., Shapkina V.A., Aksenov E.Yu., Povetyev A.V., Golubeva I.V. Efficacy of a fixed combination of paracetamol and tramadol in oral dosage form in surgical and traumatology practice. Vrach. 2021; 32 (11): 70–3. DOI: 10.29296/25877305-2021-11-14 (in Russian)].
  3. Мымрина А.Л., Туева И.А., Геллер Л.Н., Плащинский А.А., Грищенко В.А. Перспективы и возможности использования фиксированной комбинации твердой лекарственной формы парацетамола и трамадола в травматологии (послеоперационный период). Врач. 2021; 32 (12): 79–82. [Mymrina A.L., Tueva I.A., Geller L.N., Plaschinsky A.A., Grishchenko V.A. Prospects and possibilities of using a fixed combination of a solid dosage form of paracetamol and tramadol in traumatology (postoperative period). Vrach. 2021; 32 (12): 79–82. DOI: 10.29296/25877305-2021-12-13 (in Russian)].
  4. Мымрина А.Л., Геллер Л.Н., Туева И.А., Плащинский А.А., Мугатасимов И.Г. Фармакоэкономическое обоснование выбора ненаркотических анальгетиков при лекарственном обеспечении стационаров хирургических и травматологических профилей. Фармация. 2022; 71 (6): 46–51. [Mymrina A.L., Geller L.N., Tueva I.A., Plaschinskiy A.A., Mugatasimov I.G. Pharmacoeconomic justification of the choice of non-narcotic analgesics in the medicine provision of surgical and traumatological hospitals. Farmatsiya. 2022; 71 (6): 46–51. (Russian)].